Abstract:Aim: To design and synthesize a series of novel amino acid-binding 1,5-diarylpyrazole derivatives, which are intended to act as prodrugs with better aqueous solubility than celecoxib, and which will exert potent anti-inflammatory activities after being converted to their parent compounds in vivo. Methods: To introduce an amino acid, celecoxib analogs containing amino or methylamino group were synthesized first through multi-step chemical reactions. All the synthesized compounds were screened in an intact cell-based assay in vitro and in carrageenan-induced mouse paw edema in vivo. Some active compounds were selected for further evaluation in a carrageenan-induced rat paw edema model. The preliminary pharmacokinetics, experiments were conducted using high performance liquid chromatography/mass spectrometry (HPLC/MS). Results: Celecoxib, 6 of the 1,5-diarylpyrazole class of celecoxib analogs, and their amino acid derivatives (hydrochloride salts) were synthesized. In vitro screening, the hydrochloride salts showed decreased inhibitory effects on cyclooxygenase (COX)-1 and COX-2 compared with their parent compounds, but some exhibited potent anti-inflammatory activity in vivo. Compound 4a was selected for further evaluation, and its anti-inflammatory effect was equivalent to that of celecoxib after oral administration in the carrageenan-induced rat paw edema model. At three doses (25 mg/kg, 50 mg/kg, and 100 mg/kg) the percentage inhibition on edema was 20.7%, 52.6%, and 62.6% (for compound 4a) and 27.8%, 38.4%, and 40.1% (for celecoxib), respectively. Preliminary pharmacokinetic evaluations support the hypothesis that compound 4a was actually converted to its parent compound, compound 4. Conclusion: The compound bound with amino acid acts like prodrug, which can exert anti-inflammatory effect similar to celecoxib after being converted to its parent compound. This finding will be of great benefit in carrying out structural modifications of prodrug-like selective COX-2 inhibitors.

A Practical Synthesis of Amino Limonin/deoxylimonin Derivatives As Effective Mitigators Against Inflammation and Nociception.

Discovery of Deoxylimonin Δ-Lactam Derivative with Favorable Anti-Inflammation and Antinociception Efficacy from Chemical Modified Limonin/deoxylimonin Analogs.

Synthesis of Limonin Derivatives with Improved Anti-inflammatory and Analgesic Properties

Synthesis and Pharmacological Evaluation of Novel Limonin Derivatives As Anti-Inflammatory and Analgesic Agents with High Water Solubility.

Discovery of Novel Limonin Derivatives As Potent Anti-Inflammatory and Analgesic Agents.

Design, Synthesis, and in Vitro and in Vivo Biological Evaluation of Limonin Derivatives for Anti-Inflammation Therapy.

Synthesis and Biological Activity of 5-Chloro-3-(hydroxy-p-methanesulfonylphenylmethylene)-2-oxo-2,3-dihydroi Ndole-1-Carboxamides

Synthesis and Biological Activity of 3-[(4-sulfamoylphenyl)hydroxy Methylene]-5-methyl-2-oxindole-1-carboxamides

N-[2-(5,5-dimethyl-1,3-dioxane-2-yl)ethyl]amino acids: their synthesis, anti-inflammatory evaluation and QSAR analysis.

New anti-inflammatory limonoids from the fruits of Melia azedarach

Design,synthesis,and Anti-Inflammatory Evaluation of a Series of Novel Amino Acid-Binding 1,5-Diarylpyrazole Derivatives

Synthesis and Biological Evaluation of Novel Pyrazoline Derivatives As Potent Anti-Inflammatory Agents

A novel limonin derivate modulates inflammatory response by suppressing the TLR4/NF-κB signalling pathway

Synthesis and anti-inflammatory effects of novel emodin derivatives bearing azole moieties

Synthesis and Anti-Inflammatory Activity of Α-Substituted P-(Methanesulfonyl)phenylpropenamides

Design and synthesis of 1,3-benzothiazinone derivatives as potential anti-inflammatory agents

Synthesis and biological evaluation of novel 5-benzylidenethiazolidine-2,4-dione derivatives for the treatment of inflammatory diseases.

Synthesis and anti-inflammatory activity of p-(sulfamyl) benzylidene-linked heterocyclic ketone derivatives

Synthesis and Anti-Inflammatory Activity Evaluation of Novel 3-Alkyl-6-(4h-1,2,4-triazol-4-yl)-3,4-dihydro-2h-benzo[e][1,3]oxazine Derivatives

Synthesis and biological evaluation of novel sinomenine derivatives as anti-inflammatory agents.

Design, synthesis, and bioactivity evaluation of novel amide/sulfonamide derivatives as potential anti-inflammatory agents against acute lung injury and ulcerative colitis